Disclosed security · Transaction Sep 26, 2017 · Filed Oct 3, 2017 · $1,001 to $15,000
OPKO Health Inc
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is OPK moving today?
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
OPK overview
Related filings and maps
Congress activity in OPK
OPK Common Stock · Transaction Mar 2, 2017 · Filed Mar 2, 2017 · Amount pending receipt enrichment
OPK Common Stock · Transaction Feb 7, 2017 · Filed Feb 7, 2017 · Amount pending receipt enrichment
OPK contract awards, year to date.
Public federal awards linked to this ticker.
OPK lobbying filings, year to date.
Registered lobbying filings matched to OPKO Health Inc.